New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer

Rheumatology International

Volumn 28, Issue 11, 2008, Pages 1127-1135

  Murota, Hiroyuki ^a   Kotobuki, Yorihisa ^a   Umegaki, Noriko ^a   Tani, Mamori ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C Reactive protein; IL 6; Lipo prostaglandin E1; sICAM 1; Skin ulcer; VEGF

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; C REACTIVE PROTEIN; CILOSTAZOL; COLCHICINE DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INTERLEUKIN 6; LIMAPROST; LIPOPROSTAGLANDIN E1; METHOTREXATE; METHYLPREDNISOLONE; MIZORIBINE; PALXUS; PREDNISOLONE; PROSTACYCLIN; SARPOGRELATE; VASCULOTROPIN; WARFARIN;

ADULT; AGED; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; MALE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALPROSTADIL; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; COHORT STUDIES; COLLAGEN DISEASES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; RHEUMATIC DISEASES; SKIN ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49649112138     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0589-5     Document Type: Article

References (22)

1. Y Yamaguchi K Yoshikawa 2001 Cutaneous wound healing:an update J Dermatol 28 521 534
2. F Cianfarani R Tommasi CM Failla MT Viviano G Annessi M Papi G Zambruno T Odorisio 2006 Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endtherial growth factor transcription in the ulcer bed Br J Dermatol 154 34 41
3. G Lauer S Sollberg M Colo I Flamme J Sturzebecher K Mann T Krieg SA Eming 2000 Expression and proteolysis of vascular endtherial growth factor is increased in chronic wounds. J Invest Dermatol 115 12 18
4. PJ Papps SR Fallek A Gracia CT Anaki TL Back WK Duran RW Hobson 2nd 1995 Role of leukocyte activation in patients with venous stasis ulcers J Surg Res 59 553 559
5. O Frenkel E Shani I Ben-Bassat F Brok-Simoni G Rozenfeld-Granot G Kajakaro G Rechavi N Amariglio E Shinar D Danon 2002 Activated macrophages for treating skin ulceration:gene expression in human monocytes after hypo-osmotic shock Clin Exp Immunol 128 59 66
6. U Ganter R Arcone C Toniatti G Morrone G Ciliberto 1989 Dual contorol of C-reactive protein gene expression by interleukin-1 and interleukin-6 EMBO J 8 3773 3779
7. R Rothlein EA Mainolfi M Czajkowski SD Marlin 1991 A form of circulating ICAM-1 in human serum J Immunol 147 3788 3793
8. J Hahn M Junger B Friedrich D Zuder A Steins M Hahn T Klyscz 1997 Cutaneous inflammation limited to the region of the ulcer in chronic venous insufficiency Vasa 26 277 281
9. IF Rowe AC Deans 1986 Serum C-reactive protein measurement in pyoderma gangreosom Dermatologica 173 216 219
10. NM Heshmat TH EL-Kerdanv 2007 Serum levels of vascular endothrial growth factor in children and adolescents with systemic lupus erythematosus Pediatr Allergy Immunol 18 346 353
11. K Kikuchi M Kubo T Kadono N Yazawa H Ihn K Tamaki 1998 Serum concentrations of vascular endothrial growth factor in collagen diseases Br J Dermatol 139 1049 1051
12. RA Fava NJ Olsen G Spencer-Green KT Yeo B Berse RW Jackman DR Senger HF Dvorak LF Brown 1994 Vascular permeability factor/endothrial growth factor (VPF/VEGF) accumulation and expression in human synovial fluids and rheumatoid synovial tissue J Exp Med 180 341 346
13. MA Murphy WP Jovce C Condron D Bouchier-Haves 2002 A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy Eur J Vasc Endovasc Surg 23 349 352
14. SL Drinkwater KG Burnand R Ding A Smith 2003 Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers J Vasc Surg. 38 1106 1112
15. S Aoki K Imai A Yachi 1993 Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis Scand J Immunol 38 485 490
16. KP Machold HP Kiener W Graninger WB Graninger 1993 Soluble intercellular adhesion molecule-1(ICAM-1) in patients with rheumatoid arthritis and systemic lupus erthmatosus Clin Immunol Immunopathol 68 74 78
17. JJ Cush R Rothlein HB Lindslev EA Mainolfi PE Lipskv 1993 Increased levels of circulating intercellular adhesion molecute 1 in the sera of patients with rheumatoid arthritis Arthritis Rheum 36 1098 1102
18. PP Sfikakis J Tesar H Baraf R Lipnick G Klipple GO Tsokos 1993 Circulating intercellular adhesion molecute-1 in patients with systemic sclerosis Clin Immunol Immunopathol 68 88 92
19. H Kiener W Graninger K Machold M Aringer WB Graninger 1994 Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis Clin Exp Rheumatol 12 483 487
20. H Murota E Muroi T Yamaoka Y Hamasaki I Katayama 2006 Successful treatment with regimen of intravenous gamma globulin and cyclophosphamide for dermatomyositis accompanied by interstitial pneumonia, opportunistic infection and steroid psychosis Allergol Int 55 199 202
21. Y Mizushima A Yanagawa A Hoshi 1983 Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man J Pharm Pharmacol 35 666 667
22. K Tsutsui F Shirasaki M Takata K Takehara 1996 Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation Dermatology 192 120 124